NOVARTIS PHARMACEUTICALSBusiness Directories,Company Directories

Company Name: Corporate Name:	NOVARTIS PHARMACEUTICALS
Company Title:
Company Description:
Keywords to Search:
Company Address:	99 Metcalfe St,OTTAWA,ON,Canada
ZIP Code: Postal Code:	K1P
Telephone Number:	6135691742
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	0
USA SIC Description:	Government Offices-Federal
Number of Employees:
Sales Amount:
Credit History: Credit Report:	Institution
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
NOVELL CANADA LTD
NOVELL
NOVATECH DISASTER RESTORATION

Next company profile:
NOVALIS-REDACTION
NOVACOM
NOVA NETWORKS INC

Company News:

Novartis
Novartis is an innovative medicines company Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease Our medicines reach more than 250 million people worldwide
Novartis United States of America
Drug delivery, service delivery, and the future of cancer care State-of-the-art Novartis manufacturing facility in Indianapolis fortifies the foundation of an entirely new paradigm in pharmaceutical drug delivery
Novartis - Wikipedia
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022 [4] [5]
Products - Novartis
Discover the diverse and innovative Novartis Global Product Portfolio and find information about each pharmaceutical treatment
FDA approves Novartis Cosentyx® as the first new biologic treatment . . .
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as early as Week 21 As the only IL-17A inhibitor
Novartis announces new organizational structure to - GlobeNewswire
Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative Medicines US and Innovative
Novartis - LinkedIn
Novartis is an innovative medicines company Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered
3B Pharmaceuticals Announces Option and Asset Purchase Agreement with . . .
BERLIN, Germany — Berlin, Germany – October 21, 2024 – 3B Pharmaceuticals GmbH (3BP), a privately-held German biotechnology company focused on research and development of radiopharmaceutical precision therapies for cancer patients, today announced it has signed an option and asset purchase agreement with Novartis Pharma AG (Novartis) for its prostate-specific membrane antigen (PSMA) program
Novartis wins U. S. approval for targeted cancer drug combination
A targeted oral drug combination by Novartis won U S approval for use in a wide range of advanced solid tumours that are driven by a certain genetic contributor, widening the use of a novel
Novartis Appeals US Drug Price Negotiation Loss to Third Circuit
Novartis AG appealed its challenge against the Biden administration’s drug price negotiation plan to the Third Circuit after a lower court rejected its claims that the program violates speech and takes property The noticed filed Monday to the US Court of Appeals for the Third Circuit comes after Judge Zahid N Quraishi of the US District